VITILIGO

This study tests whether using ultrasound (phonophoresis) to push betamethasone cream deeper into the skin can improve vitiligo patches better than cream alone. The trial will enroll 60 adults with stable vitiligo and measure changes using a standard noticeability scale. The goal…

This study tests two similar procedures—needling and microneedling—both followed by narrowband UVB light therapy, to see which works better at bringing back skin color in people with stable non-segmental vitiligo. Eighty adults aged 15 to 60 who have had vitiligo for over a year …

This study tests a new drug called LY4005130 in 60 adults with non-segmental vitiligo, a condition causing white patches on the skin. Participants receive either the drug or a placebo by IV over 24 weeks. The goal is to see if the drug safely reduces facial and body patches bette…

This study tests whether a new gel called CGB-600 can safely reduce white patches on the face and neck caused by vitiligo. About 36 adults aged 18 to 60 will apply the gel or a placebo twice daily for 24 weeks. Researchers will check for side effects and measure changes in skin c…

This study tests a procedure where a person's own skin cells are transplanted onto stable white patches caused by vitiligo. The goal is to see how well and how long the color returns. About 30 people aged 8 to 65 with stable vitiligo covering at least 5% of their body will take p…

This study tests whether adding a 6-month course of methotrexate improves the results of a skin cell transplant (NCES) for adults with stable, hard-to-treat vitiligo on elbows and knees. Twenty participants will be split into two groups: one gets methotrexate before and after the…

This study tests whether adding narrowband UVB light therapy to the daily pill ritlecitinib works better than the pill alone for treating vitiligo. About 56 adults with non-segmental vitiligo covering 4-60% of their body will take part. The main goal is to see how much facial and…

This early-stage trial tests a new medicine called FB102 for people with non-segmental vitiligo, a condition that causes white patches on the skin. The study will include 64 adults and aims to see if the drug is safe and can help bring back skin color on the face. Participants wi…

This study tests a new topical powder that fizzes when mixed with water, delivering 5-fluorouracil to help restore skin color in people with stable vitiligo. About 60 participants aged 10 and older with patches that haven't changed for at least a year will apply the treatment. Th…

This study is testing if a procedure using tiny needles (microneedling) with a drug called 5FU works better than a strong steroid cream to bring back skin color in small patches of vitiligo. Researchers will compare the two treatments in 40 people with stable vitiligo over 12 wee…

This study looks at how well ruxolitinib cream works for people with vitiligo, a condition that causes white patches on the skin. Researchers want to find out what factors help the cream work best. About 170 people aged 12 and older with mild to moderate vitiligo will take part. …